{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:35:48Z","timestamp":1791750948542,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10067-024-07127-8","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T08:04:08Z","timestamp":1726473848000},"page":"3273-3283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Disease activity score for still\u2019s disease"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5669-5759","authenticated-orcid":false,"given":"Karima","family":"Daghor-Abbaci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazim","family":"Laraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chafia","family":"Dahou-Makhloufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Mechid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ait-Hamadouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Makrelouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Otmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fifi","family":"Otmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourredine","family":"Smail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Boucelma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima","family":"Lefkir-Teffiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Bengana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Boukhris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Boughandjioua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baya","family":"Taharbouchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Oumnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chafika","family":"Haouichet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fella","family":"Hanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nacera","family":"Benfenatki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelkrim","family":"Berrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"7127_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41584-023-01065-6","volume":"20","author":"P Ruscitti","year":"2024","unstructured":"Ruscitti P et al (2024) Recent advances and evolving concepts in Still\u2019s disease. Nat Rev Rheumatol 20:116\u2013132","journal-title":"Nat Rev Rheumatol"},{"key":"7127_CR2","unstructured":"Bindoli S et al.(2023) Efficacy and safety of therapeutic interventions for the treatment of Still\u2019s disease: a systematic review and meta-analysis informing the EULAR\/PReS recommendations for the diagnosis and management of systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease. Arthritis Rheumatol 75 (Suppl. 9), Abstr. 2569"},{"key":"7127_CR3","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al (1992) Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol 19:424\u2013430","journal-title":"J Rheumatol"},{"key":"7127_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","volume":"81","author":"B Fautrel","year":"2002","unstructured":"Fautrel B, Zing E, Golmard JL, LeMoel G, Bissery A, Rioux C et al (2002) Proposal for a newset of classification criteria for adult-onset still disease. Med (Baltimore) 81:194\u2013200","journal-title":"Med (Baltimore)"},{"key":"7127_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10067-023-06509-8","volume":"42","author":"Daghor-Abbaci","year":"2023","unstructured":"Daghor-Abbaci et al (2023) Proposal of a new diagnostic algorithm for adult onset Still\u2019s disease. Clin Rheumatol 42:1125\u20131135","journal-title":"Clin Rheumatol"},{"key":"7127_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux I, Iwaz J, S\u00e8ve P (2014) Adult onset Still\u2019s disease. Autoimmun Rev 13:708\u2013712","journal-title":"Autoimmun Rev"},{"key":"7127_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.semarthrit.2010.12.006","volume":"41","author":"M Colina","year":"2011","unstructured":"Colina M, Zucchini W, Ciancio G, Orzincolo C, Trotta F, Govoni M (2011) The evolution of adult-onset Still\u2019s disease: an observational and comparative study in a cohort of 76 Italian patients. Semin Arthritis Rheum 41:279\u2013285","journal-title":"Semin Arthritis Rheum"},{"key":"7127_CR8","doi-asserted-by":"publisher","unstructured":"Abbaci-Daghor K, Berrah A (2019) Severe destructive arthritis in adult onset Still\u2019s disease. Rheumatol Adv Pract 3(1):rky052. https:\/\/doi.org\/10.1093\/rap\/rky052","DOI":"10.1093\/rap\/rky052"},{"issue":"6","key":"7127_CR9","first-page":"136","volume":"15","author":"R Munagala","year":"2012","unstructured":"Munagala R, Misra R, Agarwal V, Lawrence A, Aggarwal A (2012) Adult onset Still\u2019s disease: experience from a tertiary care rheumatology unit. Int J Rheum Dis 15(6):136\u2013141","journal-title":"Int J Rheum Dis"},{"key":"7127_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/MD.0b013e3181caf100","volume":"89","author":"A Hot","year":"2010","unstructured":"Hot A, Toh ML, Copp\u00e9r\u00e9 B, Perard L, Girard-Madoux MH, Mausservey C et al (2010) Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients. Medicine (Baltimore) 89:37\u201346","journal-title":"Medicine (Baltimore)"},{"key":"7127_CR11","doi-asserted-by":"publisher","unstructured":"Abbaci Daghor K, Otmane A, Makrelouf M et al (2021) Prognostic factors in adult onset Still\u2019s disease. Arch Rheum & Arthritis Res. 1(5) ARAR.MS.ID.000523. https:\/\/doi.org\/10.33552\/ARAR.2021.01.000523","DOI":"10.33552\/ARAR.2021.01.000523"},{"key":"7127_CR12","doi-asserted-by":"publisher","unstructured":"-Bindoli S et al. Adult\u2011onset Still\u2019s disease (AOSD): advances in understanding pathophysiology, genetics and emerging treatment options. Drugs. https:\/\/doi.org\/10.1007\/s40265-024-01993","DOI":"10.1007\/s40265-024-01993"},{"key":"7127_CR13","first-page":"840","volume":"77","author":"C Gabay","year":"2018","unstructured":"Gabay C, Fautrel B, Rech B, Spertini F, Feist E, K\u00f6tter I (2018) Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of Tadekinig alfa (IL-18BP) in adult-onset Still\u2019s disease. Ann Rheum Dis 77:840\u2013847","journal-title":"Ann Rheum Dis"},{"key":"7127_CR14","first-page":"194","volume":"14","author":"P Ruscitti","year":"2016","unstructured":"Ruscitti P, Cipriani P, Masedu F, Lacono D, Ciccia F, Liakouli V (2016) Adult onset Still\u2019s disease\u202f: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three center. Medicine 14:194","journal-title":"Medicine"},{"issue":"11","key":"7127_CR15","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3899\/jrheum.100247","volume":"37","author":"M Rau","year":"2010","unstructured":"Rau M, Schiller M, Krienke S, Heyder P, Lorenz H, Blank N (2010) Clinical manifestations but not cytokine profiles differentiate adult-onset Still\u2019s disease and sepsis. J Rheumatol 37(11):2369\u20132376","journal-title":"J Rheumatol"},{"key":"7127_CR16","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/rheumatology\/keaa240","volume":"59","author":"J Tibaldi","year":"2020","unstructured":"Tibaldi J, Pistzerio A, Aldera E (2020) Development and initial validation of a composite DAS for systemic JIA. Rheumatology 59:3505\u20133514. https:\/\/doi.org\/10.1093\/rheumatology\/keaa240","journal-title":"Rheumatology"},{"key":"7127_CR17","doi-asserted-by":"publisher","first-page":"12810","DOI":"10.3390\/ijms232112810","volume":"23","author":"LA Macovei","year":"2022","unstructured":"Macovei LA et al (2022) Adult-onset Still\u2019s disease\u2014a complex disease, a challenging treatment. Int J Mol Sci 23:12810. https:\/\/doi.org\/10.3390\/ijms232112810","journal-title":"Int J Mol Sci"},{"key":"7127_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","volume":"70","author":"J Pouchot","year":"1991","unstructured":"Pouchot J, Sampalis JS, Beaudet F, Carette S, D\u00e9cary F, Salusinsky-Sternbach M et al (1991) Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70:118\u2013136","journal-title":"Medicine (Baltimore)"},{"key":"7127_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist E, Mitrovic S, Fautrel B (2018) Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease. Nat Rev Rheumatol 14:603\u2013618. https:\/\/doi.org\/10.1038\/s41584-018-0081","journal-title":"Nat Rev Rheumatol"},{"key":"7127_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/MD.0000000000029970","volume":"101","author":"K Daghor-Abbaci","year":"2022","unstructured":"Daghor-Abbaci K, Ait Hamadouche N, Otmani F et al (2022) Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still\u2019s disease. Medicine 101:32","journal-title":"Medicine"},{"key":"7127_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/rheumatology\/kead461","volume":"00","author":"HL Leavis","year":"2023","unstructured":"Leavis HL et al (2023) Management of adult-onset Still\u2019s disease: evidence- and consensus-based recommendations by experts. Rheumatology 00:1\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/kead461","journal-title":"Rheumatology"},{"key":"7127_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13075-017-1346-5","volume":"19","author":"Schoels","year":"2017","unstructured":"Schoels et al (2017) Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition. Arthritis Res Ther 19:155","journal-title":"Arthritis Res Ther"},{"key":"7127_CR23","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.3390\/ijms222413320","volume":"22","author":"B Maranini","year":"2021","unstructured":"Maranini B, Ciancio G, Govoni M (2021) Adult-onset Still\u2019s disease: novel biomarkers of specific subsets, disease activity, and relapsing forms. Int J Mol Sci 22:13320. https:\/\/doi.org\/10.3390\/ijms222413320","journal-title":"Int J Mol Sci"},{"key":"7127_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/acr.20319","volume":"63","author":"X Pu\u00e9chal","year":"2011","unstructured":"Pu\u00e9chal X, DeBandt M, Berthelot J-M, Breban M, Dubost J-J, Fain O et al (2011) Toci-lizumab in refractory adult Still\u2019s disease. Arthritis Care Res 63:155\u2013159","journal-title":"Arthritis Care Res"},{"key":"7127_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fphar.2019.00296","volume":"10","author":"A Vitale","year":"2019","unstructured":"Vitale A, Cavalli G, Colafrancesco S, Priori R, Valesini G, Argolini LM (2019) Long-term retention rate of anakinra in adult onset Still\u2019s disease and predictive factors for treatment response. Front Pharmacol 10:296","journal-title":"Front Pharmacol"},{"key":"7127_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/ard.2007.076034","volume":"67","author":"T Lequerr\u00e9","year":"2008","unstructured":"Lequerr\u00e9 T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O et al (2008) Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 67:302\u2013308","journal-title":"Ann Rheum Dis"},{"key":"7127_CR27","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.3899\/jrheum.111549","volume":"39","author":"D Nordstr\u00f6m","year":"2012","unstructured":"Nordstr\u00f6m D, Knight A, Luukkainen R, van Vollenhoven R, Rantalaiho V, Kaja-lainen A et al (2012) Beneficial effect of interleukin 1 inhibition with anakinra inadult-onset Still\u2019s disease. An open, randomized, multicenter study. J Rheumatol 39:2008\u201311","journal-title":"J Rheumatol"},{"key":"7127_CR28","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1136\/annrheumdis-2013-203666","volume":"73","author":"M Piram","year":"2014","unstructured":"Piram M, Kon\u00e9-Paut I, Lachmann HJ et al (2014) Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis 73:2168\u20132173","journal-title":"Ann Rheum Dis"},{"key":"7127_CR29","doi-asserted-by":"publisher","first-page":"92936","DOI":"10.1002\/acr.20497","volume":"63","author":"CA Wallace","year":"2011","unstructured":"Wallace CA, Giannini EH, Huang B et al (2011) American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 63:92936","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7127_CR30","doi-asserted-by":"publisher","first-page":"105499","DOI":"10.1016\/j.jbspin.2022.105499","volume":"90","author":"U Kalyoncu","year":"2023","unstructured":"Kalyoncu U, Kasifoglu T, Omma A et al (2023) Derivation and validation of adult Still Activity Score (SAS). Joint Bone Spine 90:105499","journal-title":"Joint Bone Spine"},{"key":"7127_CR31","first-page":"S0896","volume":"16","author":"U Kalyoncu","year":"2016","unstructured":"Kalyoncu U, Solwaz D, Emmungil H, Yazici A, Kasifoglu T, Kimyon G et al (2016) Response rate of initial conventional treatments, disease course and related factors of patients with adult onset Still disease: data from a large multicenter cohort. J Autoimmun 16:S0896-8411","journal-title":"J Autoimmun"},{"key":"7127_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13075-019-1838-6","volume":"21","author":"F Vercruysse","year":"2019","unstructured":"Vercruysse F, Barnetche T, Lazaro E, Shipley E, Lifermann F, Balageas A (2019) Adult-onset Still\u2019s disease biological treatment strategy may depend on the phenotypic dichotomy. Arthritis Res Ther 21:53","journal-title":"Arthritis Res Ther"},{"key":"7127_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13075-019-1843-9","volume":"21","author":"G Cavalli","year":"2019","unstructured":"Cavalli G, Tomelleri A, De Luca G, Campochiaro C, Dinarello C, Baldissera E, Dagna L (2019) Efficacy of canakinumab as first-line biologic agent in adult-onset Still\u2019s disease. Arthritis Res Ther 21:54","journal-title":"Arthritis Res Ther"},{"key":"7127_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/jcm10040733","volume":"10","author":"S Tomaras","year":"2021","unstructured":"Tomaras S, Goetzke CC, Kallinich T, Feist E (2021) Adult-onset Still\u2019s disease: clinical aspects and therapeutic approach. J Clin Med 10:733. https:\/\/doi.org\/10.3390\/jcm10040733","journal-title":"J Clin Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07127-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T09:05:44Z","timestamp":1729242344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07127-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7127"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07127-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}